Latest Capital Structure News

Sigma Healthcare has achieved unanimous shareholder approval for its proposed merger with Chemist Warehouse, marking a pivotal step toward reshaping Australia's pharmaceutical retail landscape. The merger now awaits final court approval, with implementation anticipated in mid-February 2025.

Redivium's Q2 FY25 report reveals strategic progress in lithium-ion battery recycling across Europe, including new partnerships and feasibility studies, while navigating tight cash reserves and a critical entitlement offer.

Aurum Resources has announced the suspension of trading and imminent delisting of Mako Gold from the ASX following its successful takeover. Mako shareholders are urged to accept the offer before the deadline to avoid delays in payment.

Hudson Investment Group signals potential corporate restructure as it explores sale and joint venture options for key Queensland and NSW properties.

Skylark Minerals has reshaped its leadership team with seasoned gold industry veterans and agreed to divest its Citronen Zn-Pb Project, positioning the company for renewed growth and exploration success.

Jervois Global Limited has initiated a prepackaged Chapter 11 recapitalisation process in the US, leading to the suspension of its shares on multiple exchanges. Shareholders are being notified with detailed documentation as the company seeks to restructure its finances.

Algorae Pharmaceuticals reports robust progress in its drug development pipeline, highlighted by promising preclinical results for cardiovascular and dementia candidates and significant AI platform enhancements.

Develop Global Limited reported a robust increase in cash reserves for the December 2024 quarter, driven by significant financing inflows despite ongoing operational and investing outflows.

Imugene Limited has secured A$20 million through convertible notes as part of a broader A$46 million capital raise, aiming to advance its promising immuno-oncology pipeline.

Meeka Metals Limited reports a strong cash position of $55.259 million as of December 31, 2024, underpinning its exploration activities with nearly 30 quarters of funding available. Despite ongoing cash outflows from exploration and corporate costs, the company’s financial footing remains robust.

Hiremii Limited reports a modest 0.4% revenue increase to $7.5 million in Q2 FY25, underpinned by strategic AI platform deployment and expanding Energy Transition sector opportunities.

Aurumin Limited has entered a potentially lucrative joint venture with Newcam Minerals for iron ore rights worth up to $7 million, while advancing gold exploration with significant drilling at its Central Sandstone Project.